Pasithea Therapeutics Corp. (KTTAW) Total Non-Current Liabilities (2021 - 2026)

Pasithea Therapeutics has disclosed Total Non-Current Liabilities across 6 years of filings, most recently posting $32341.0 for Q2 2026.

• In Q2 2026, Total Non-Current Liabilities fell 65.5% year-over-year to $32341.0; the TTM figure through Jun 2026 stood at $32341.0 (down 65.5% YoY), while the FY2025 annual figure was $46871.0, down 71.1% from the prior year.
• Total Non-Current Liabilities came in at $32341.0 for Q2 2026 at Pasithea Therapeutics, down from $52966.0 in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $1.3 million in Q3 2022 to a low of $32341.0 in Q2 2026.
• Average Total Non-Current Liabilities over 5 years is $314335.7, with a median of $127956.5 recorded in 2024.
• Year-over-year, Total Non-Current Liabilities soared 147.21% in 2022 and tumbled 92.68% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $804207.0 in 2022, then plunged by 89.51% to $84366.0 in 2023, then soared by 92.22% to $162172.0 in 2024, then slumped by 71.1% to $46871.0 in 2025, then tumbled by 31.0% to $32341.0 in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $32341.0 in Q2 2026, $52966.0 in Q1 2026, and $46871.0 in Q4 2025.